On Monday, Pacific Biosciences of California Inc (NASDAQ: PACB) opened higher 14.08% from the last session, before settling in for the closing price of $1.42. Price fluctuations for PACB have ranged from $0.85 to $2.72 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -23.55%. Company’s average yearly earnings per share was noted -67.14% at the time writing. With a float of $266.29 million, this company’s outstanding shares have now reached $300.35 million.
Considering the fact that the conglomerate employs 575 people, you should pay attention to its efficiency factor.
Pacific Biosciences of California Inc (PACB) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pacific Biosciences of California Inc is 11.35%, while institutional ownership is 56.84%. The most recent insider transaction that took place on Aug 18 ’25, was worth 35,182. In this transaction an insider of this company sold 26,836 shares at a rate of $1.31, taking the stock ownership to the 1,920,035 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Officer proposed sale 26,836 for $1.31, making the entire transaction worth $35,174.
Pacific Biosciences of California Inc (PACB) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.17 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.21) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -67.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.21% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Check out the current performance indicators for Pacific Biosciences of California Inc (PACB). In the past quarter, the stock posted a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.27, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.53 in one year’s time.
